e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
COPD: from biomarker profiling to clinical assessment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled breath molecular profiling by electronic nose in non-pulmonary malignancies
J. van der Maten, P. J. Sterk, A. Ten Brinke (Leeuwarden, Amsterdam, Netherlands)
Source:
Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Session:
COPD: from biomarker profiling to clinical assessment
Session type:
E-Communication Session
Number:
3160
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. van der Maten, P. J. Sterk, A. Ten Brinke (Leeuwarden, Amsterdam, Netherlands). Exhaled breath molecular profiling by electronic nose in non-pulmonary malignancies. Eur Respir J 2009; 34: Suppl. 53, 3160
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Exhaled biomarkers in lung cancer
Source: Eur Respir J 2009; 34: 261-275
Year: 2009
Exhaled breath molecular profiling in measuring inflammatory status in COPD
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Exhaled breath analysis using eNose technology in patients with sarcoidosis
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020
Exhaled breath collection by electronic nose: methods of measurement
Source: Eur Respir J 2006; 28: Suppl. 50, 790s
Year: 2006
Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005
Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Sensors for detecting pulmonary diseases from exhaled breath
Source: Eur Respir Rev, 28 (152) 190011; 10.1183/16000617.0011-2019
Year: 2019
Exhaled breath temperature in airways disease
Source: Eur Respir J 2003; 22: 393-394
Year: 2003
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Protein markers in the exhaled breath condensate of lung carcinoma patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Exhaled breath condensates and COPD
Source: Eur Respir J 2009; 33: 1238
Year: 2009
Exhaled breath condensate: metabolomics
Source: Eur Respir Monogr 2010; 49: 231-236
Year: 2010
Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept